Glenmark tops the charts in US
US approve the sale of low cost medicines by Glenmark Pharmaceuticals this financial year by winning the bids against Sun Pharma, Ranbaxy Laboratories and Dr Reddy.
US approve the sale of low cost medicines by Glenmark Pharmaceuticals this financial year by winning the bids against Sun Pharma, Ranbaxy Laboratories and Dr Reddy.
Mount Kellett Capital Management , US private equity group, is investing Rs 410 crore in one of India’s top pharma retailer MedPlus Health Services.
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
Aurbindo pharma looses 0.91 percent stakes possessed by HSBC Global Investment Funds (Mauritius) Ltd in the open market sales.
Pfizer loses $10-billion-a-year revenue in November this year as its major cholesterol drug Lipitor patent expires.
Microsoft and HIMSS launch Health Users Group in APAC Microsoft Corp and Healthcare Information and Management Systems Society (HIMSS) have […]
Cerner moves into Ireland Cerner, a leading international supplier of healthcare information technology (HIT) solutions, recently announced the opening of […]
An e-healthy gift to USA's ageing population Getting a head-start on assessment and intervention for age-related conditions such as Alzheimer's […]
Indian drug makers are now tapping their feet to become the world
Virtual reality systems increasingly are being integrated into a wide variety of health-related settings according to a new report from Kalorama Information, Healthcare IT News reports.
The electronic health record market grew to $15.7 billion in 2010, according to a new report by Kalorama Information, Healthcare IT News reports.